Share this post:

Clive Cookson covers the Antimicrobial Resistance Benchmark, focusing on the key findings on the performance of large research-based pharmaceutical companies, generic medicine manufacturers and biopharmaceutical companies in the scope of analysis.

 

Read full article Download full article